Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yves, Brault"'
Autor:
Régis Coutant, Maithé Tauber, Béatrice Demaret, Robin Henocque, Yves Brault, François Montestruc, Olivier Chassany, Michel Polak
Publikováno v:
Endocrine Connections, Vol 12, Iss 4, Pp 1-11 (2023)
Objective: The objective of this study was to describe in a real-life set ting the treatment burden and adherence and quality of life (QOL) of children trea ted with daily injections of growth hormone and their relationship with treatment duration.
Externí odkaz:
https://doaj.org/article/617b536bf6354ab49665e57e56c4dffa
Autor:
Maxime Dougados, Peter C Taylor, Clifton O Bingham, Lisy Wang, Lara Fallon, Satrajit Roychoudhury, Yves Brault, Meriem Kessouri
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective Post hoc analysis of pooled data from nine randomised controlled trials to assess the effect of tofacitinib (oral Janus kinase inhibitor for treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA)) on residual pain in patients
Externí odkaz:
https://doaj.org/article/718c987b34ca40a3929222a0f56b3617
Autor:
Robin Henocque, Thierry Brue, Brigitte Delemer, Yves Brault, Christine Cortet-Rudelli, Gérald Raverot, Hervé Lefebvre, Rachel Desailloud, Isabelle Raingeard, Philippe Caron, Sara Barraud, Philippe Chanson
Publikováno v:
Annales d'Endocrinologie
Annales d'Endocrinologie, Elsevier Masson, 2021, 82 (6), pp.582-589. ⟨10.1016/j.ando.2021.05.004⟩
Annales d'Endocrinologie, Elsevier Masson, 2021, 82 (6), pp.582-589. ⟨10.1016/j.ando.2021.05.004⟩
Objective We report the final analysis of the French ACROSTUDY, using data revised and enriched since the 2013 interim analysis. Our objective was to validate the use of pegvisomant (PEGV) in the treatment of acromegaly and to determine efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::256050e0d0ba76fe220f37799c66c569
https://hal.archives-ouvertes.fr/hal-03366670
https://hal.archives-ouvertes.fr/hal-03366670
Autor:
Clifton O. Bingham, John Woolcott, M. Kessouri, Lisy Wang, Peter C. Taylor, D. van der Heijde, Maxime Dougados, Yves Brault, Lara Fallon
Publikováno v:
Annals of the Rheumatic Diseases. 79:760-761
Background:Current treatments for PsA have proven effective in reducing patient (pt)-reported pain;1,2however, residual pain often remains. Tofacitinib is an oral Janus kinase inhibitor for the treatment of PsA.Objectives:This descriptive analysis ev
Autor:
Emmanuelle Kuhn, Philippe Caron, Brigitte Delemer, Isabelle Raingeard, Hervé Lefebvre, Gérald Raverot, Christine Cortet-Rudelli, Rachel Desailloud, Clementine Geffroy, Robin Henocque, Yves Brault, Thierry Brue, Philippe Chanson
Publikováno v:
Endocrine. 71:265-265
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Autor:
Lotus Mallbris, Dagmar Wilsmann-Theis, Jean-Michel Germain, Valentina Marino, Giuseppe Micali, Yves Brault, Gaia Gallo
Publikováno v:
Acta Dermato Venereologica. 95:57-61
Cyclosporine is an established therapy for psoriasis that provides rapid relief of symptoms but has long-term toxic side effects. The objective of this study was to demonstrate the efficacy of etanercept as replacement therapy for cyclosporine in pat
Publikováno v:
Journal of Rheumatology, 41(10), 1922-1934
Objective.The objective of these posthoc analyses was to evaluate short-term clinical outcomes as predictors of poor response after 1 year of treatment with combination etanercept/methotrexate (ETN/MTX) therapy versus MTX monotherapy in patients with
Autor:
Camillo Porta, Lucile Serfass, Yves Brault, Gwénaël Denechere, James Larkin, Stéphane Oudard, Nuno Costa, Manuela Schmidinger
Publikováno v:
Journal of Clinical Oncology. 37:606-606
ADONIS is an ongoing observational study in 9 European countries, designed to evaluate treatment patterns/outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with first-line sunitinib and/or second-line axitinib post sunitinib. W
Autor:
D. van der Heijde, Isabelle Logeart, Yves Brault, Walter Grassi, Peter V. Balint, M.A. D'Agostino, Marina Backhaus, E. De Miguel, Richard J. Wakefield, Maxime Dougados, Peter Mandl
Publikováno v:
Arthritis Care & Research. 65:879-887
Objective To evaluate the metrologic properties of composite disease activity indices in rheumatoid arthritis (RA), utilizing information derived from clinical, gray-scale (GS), and power Doppler (PD) ultrasound examinations, and to assess the classi
Publikováno v:
Clinical and experimental rheumatology. 35(5)
In rheumatoid arthritis, quality of sleep and ability to cope are important for patients; however their usefulness as outcome measures is not well established.Post-hoc analysis of an open-label 12-week trial of etanercept in biologic-naïve rheumatoi